肠道微生物组合,血清炎症标记物和便短链脂肪酸在1型和2型糖尿病患者中与健康对照者的比较:一个病例对照研究
Hossein Yarmohammadi1,2, Masood Soltanipur1,3, Mahdi Rezaei1,4
1Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
与健康个体相比,1型和2型糖尿病呈现出明显的肠道微生物组变化,炎症标志物增加和短链脂肪酸变化. 这些发现表明,在糖尿病管理中,有潜在的微生物组向疗法.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 代谢学 代谢学 代谢学
背景情况:
- 糖尿病 (DM),包括1型 (T1DM) 和2型 (T2DM),与全身炎症和代谢失调有关.
- 肠道微生物组 (GM) 在宿主新陈代谢和免疫功能中起着至关重要的作用,其改变与包括糖尿病在内的各种疾病有关.
研究的目的:
- 为了比较T1DM,T2DM和健康对照个体之间的肠道微生物组合,血清炎症标记物和便短链脂肪酸 (SCFA).
- 识别与不同类型糖尿病相关的特定微生物和代谢特征.
主要方法:
- 一项涉及49名T2DM患者,21名T1DM患者和40名健康对照者的病例控制研究.
- 使用ELISA对血清炎症标志物 (CRP,IL-1β,IL-6,TNF-α,IFN-γ) 的分析.
- 通过RT-qPCR和下一代测序 (NGS) 来量化细菌种群.
- 使用气相色谱分析便代谢物,包括SCFA.
主要成果:
- 与对照组相比,在T1DM和T2DM患者中观察到肠道微生物群多样性的增加 (辛普森的α多样性).
- 细菌属频率的明显变化被注意到,T2DM中增加了Gemmiger,Dorea,Collinsella,并减少了Romboutsia和Clostridium,T1DM中降低了Prevotella,Bacteroides和Faecalibacterium.
- 在糖尿病患者中发现血清炎症标志物 (hs-CRP,IL-1β,TNF,IL-6,IFN-γ) 的升高.
- 在T2DM患者中,便中的酸盐,酸盐和丁酸盐水平显著更高,而丁酸盐与对照组相比,在两组糖尿病患者中均降低.
结论:
- 肠道微生物组合,炎症概况和SCFA生产的显著变化与T1DM和T2DM有关.
- 这些发现凸显了针对肠道微生物群作为糖尿病管理的辅助治疗策略的潜力.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
11:22Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
